Intracellular SPIO labeling of microglia: High field considerations and limitations for MR microscopy

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 121-129

  Rosenberg, Jens T ^a,b   Sachi Kocher, Afi ^b   Davidson, Michael W ^a,b   Grant, Samuel C ^a,b  

^a FLORIDA STATE UNIVERSITY   (United States)

^b FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Bv2 microglia cells; Contrast agents; High field; MR microscopy; Relaxometry; SPIO

Indexed keywords

IRON; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL LABELING; CELL VIABILITY; INCUBATION TIME; MAGNETIC FIELD; MASS SPECTROMETRY; MICROGLIA; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; CELL COUNT; CELL LINE; CELL SURVIVAL; FERROCYANIDES; INTRACELLULAR SPACE; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROGLIA; MICROSCOPY; RATS; SPECTROPHOTOMETRY, ATOMIC; STAINING AND LABELING;

EID: 84858735986     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.470     Document Type: Article

References (43)

1. Vaughan T, DelaBarre L, Snyder C, Tian J, Akgun C, Shrivastava D, Liu W, Olson C, Adriany G, Strupp J, Andersen P, Gopinath A, van de Moortele PF, Garwood M, Ugurbil K. 9.4T human MRI: preliminary results. Magn Reson Med 2006; 56(6): 1274-1282.
2. Friedrich KM, Chang G, Vieira RL, Wang L, Wiggins GC, Schweitzer ME, Regatte RR. In vivo 7.0-tesla magnetic resonance imaging of the wrist and hand: technical aspects and applications. Semin Musculoskelet Radiol 2009; 13(1): 74-84.
3. Matsusue E, Ogawa T. Clinical applications of 3.0T magnetic resonance system in the neuroradiological field. Brain Nerve 2007; 59(5): 479-485.
4. Scarabino T, Giannatempo GM, Popolizio T, Tosetti M, d'Alesio V, Esposito F, Di Salle F, Di Costanzo A, Bertolino A, Maggialetti A, Salvolini U. 3.0-T functional brain imaging: a 5-year experience. Radiol Med 2007; 112(1): 97-112.
5. van de Ven RC, Hogers B, van den Maagdenberg AM, de Groot HJ, Ferrari MD, Frants RR, Poelmann RE, van der Weerd L, Kiihne SR. T(1) relaxation in in vivo mouse brain at ultra-high field. Magn Reson Med 2007; 58(2): 390-395.
6. DiFrancesco MW, Rasmussen JM, Yuan W, Pratt R, Dunn S, Dardzinski BJ, Holland SK. Comparison of SNR and CNR for in vivo mouse brain imaging at 3 and 7T using well matched scanner configurations. Med Phys 2008; 35(9): 3972-3978.
7. Ma Y, Hof PR, Grant SC, Blackband SJ, Bennett R, Slatest L, McGuigan MD, Benveniste H. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience 2005; 135(4): 1203-1215.
8. CDRH. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices by the Center for Devices and Radiological Health. Guidance for Industry and FDA Staff 2003 (July 13).
9. Fu R, Brey WW, Shetty K, Gor'kov P, Saha S, Long JR, Grant SC, Chekmenev EY, Hu J, Gan Z, Sharma M, Zhang F, Logan TM, Bruschweller R, Edison A, Blue A, Dixon IR, Markiewicz WD, Cross TA. Ultra-wide bore 900MHz high-resolution NMR at the national high magnetic field laboratory. J Magn Reson 2005; 177(1): 1-8.
10. Fetler L, Amigorena S. Neuroscience. brain under surveillance: the microglia patrol. Science 2005; 309(5733): 392-393.
11. Yokoyama A, Yang L, Itoh S, Mori K, Tanaka J. Microglia, a potential source of neurons, astrocytes, and oligodendrocytes. Glia 2004; 45(1): 96-104.
12. Graeber MB, Streit WJ. Microglia: biology and pathology. Acta Neuropathol 2010; 119(1): 89-105.
13. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004; 39(1): 56-63.
14. Petry KG, Boiziau C, Dousset V, Brochet B. Magnetic resonance imaging of human brain macrophage infiltration. Neurotherapeutics 2007; 4(3): 434-442.
15. Corot C, Petry KG, Trivedi R, Saleh A, Jonkmanns C, Le Bas JF, Blezer E, Rausch M, Brochet B, Foster-Gareau P, Baleriaux D, Gaillard S, Dousset V. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 2004; 39(10): 619-625.
16. Henning EC, Ruetzler CA, Gaudinski MR, Hu TC, Latour LL, Hallenbeck JM, Warach S. Feridex preloading permits tracking of CNS-resident macrophages after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 2009; 29(7): 1229-1239.
17. Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Modder U, Jander S. Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 2007; 38(10): 2733-2737.
18. Nighoghossian N, Wiart M, Cakmak S, Berthezene Y, Derex L, Cho TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P, Froment JC, Hermier M. Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 2007; 38(2): 303-307.
19. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17(7): 484-99.
20. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab 2002; 22(8): 899-907.
21. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175(2): 489-493.
22. 1 relaxivity in solutions containing Gd-DTPA. Invest Radiol 1988; 23(suppl 1): S264-266.
23. Terreno E, Geninatti Crich S, Belfiore S, Biancone L, Cabella C, Esposito G, Manazza AD, Aime S. Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons. Magn Reson Med 2006; 55(3): 491-497.
24. Aime S, Dastru W, Crich SG, Gianolio E, Mainero V. Innovative magnetic resonance imaging diagnostic agents based on paramagnetic Gd(III) complexes. Biopolymers 2002; 66(6): 419-428.
25. Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolio E, Maggioni F. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imag 2002; 16(4): 394-406.
26. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999; 76(1 Pt 1): 103-109.
27. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992; 25(1): 148-157.
28. Bulte JW, Ma LD, Magin RL, Kamman RL, Hulstaert CE, Go KG, The TH, de Leij L. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 1993; 29(1): 32-37.
29. Bulte JW, Laughlin PG, Jordan EK, Tran VA, Vymazal J, Frank JA. Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry. Acad Radiol 1996; 3 (Suppl 2): S301-303.
30. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168(2): 297-301.
31. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175(2): 494-498.
32. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999; 96(26): 15256-15261.
33. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152(1): 167-173.
34. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005; 235(1): 155-161.
35. Koval M, Preiter K, Adles C, Stahl PD, Steinberg TH. Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res 1998; 242(1): 265-273.
36. Kavet RI, Brain JD. Phagocytosis: quantification of rates and intercellular heterogeneity. J Appl Physiol 1977; 42(3): 432-427.
37. Strijkers GJ, Hak S, Kok MB, Springer CS Jr, Nicolay K. Three-compartment T(1) relaxation model for intracellular paramagnetic contrast agents. Magn Reson Med 2009; 61(5): 1049-1058.
38. Rosenberg JT, Kogot JM, Lovingood DD, Strouse GF, Grant SC. Intracellular bimodal nanoparticles based on quantum dots for high-field MRI at 21.1T. Magn Reson Med 2010; 64(3): 871-882.
39. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48(1): 52-61.
40. Klug G, Kampf T, Bloemer S, Bremicker J, Ziener CH, Heymer A, Gbureck U, Rommel E, Noth U, Schenk WA, Jakob PM, Bauer WR. Intracellular and extracellular T(1) and T(2) relaxivities of magneto-optical nanoparticles at experimental high fields. Magn Reson Med 2010; 64(6): 1607-1615.
41. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19(12): 1141-1147.
42. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med 2005; 53(2): 312-320.
43. Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Eur Radiol 2006; 16(3): 738-745.